Drugs / Therapeutic HBV vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01326546 | Jun 2010 → Jan 2014 | chronic hepatitis B virus infection | Chongqing Jiachen Biotechnology Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Therapeutic HBV vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01326546 ↗ |
| Modality | Vaccine | “Therapeutic Hepatitis B Vaccine (Mimogen-based)” NCT01326546 ↗ |